Point72 Asset Management, L.P.

13F Holdings History for Regulus Therapeutics Inc. - Common Stock, par value $0.001 per share (RGLS)

Symbol: RGLS on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 241K shares
Security Ownership: 0.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Point72 Asset Management, L.P. ownership in Regulus Therapeutics Inc. Common Stock, par value $0.001 per share (RGLS)

2025-08-14 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 241K shares of Regulus Therapeutics Inc. Common Stock, par value $0.001 per share (RGLS). This represents 0.3% percent ownership of the company. In their previous filing dated 2025-04-08, Point72 Asset Management, L.P. had reported owning 3.92M shares, indicating a decrease of -93.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Point72 Asset Management, L.P.	0.3%	-93.3%	$1.9M	241K	-3,682,649	-93.9%	$7.87	13G/A	6/30/2025	14 Aug 2025 17:23:43
Point72 Asset Management, L.P.	5.9%		$6.75M	3.92M			$1.72	13G	4/1/2025	8 Apr 2025 16:30:22

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025		-0.01%	$0	0	-1,968,293	-100%		Q2 2025
3/31/2025	0.01%	+0.01%	$3.44M	1.97M	+1,073,165	+120%	$1.75	Q1 2025
12/31/2024	0%	+0%	$1.41M	895K	+1,366	+0.15%	$1.58	Q4 2024
9/30/2024	0%	+0%	$1.4M	894K	+893,762	NEW	$1.57	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.